Choose Safety Profile Adverse reactions reported in 3% of Wegovy 2.4 mg injection-treated adolescent patients aged 12 years and older with obesity and more frequently than with placebo 1 Gastrointestinal disorders were the most frequent adverse events with Wegovy ( 62% vs 42% with placebo) 2.3% of patients treated with Wegovy vs 1.5% of patients who received placebo discontinued treatment as a result of gastrointestinal adverse events 6 Mean increases in resting heart rate of 1.2 beats per minute from baseline were observed with patients taking Wegovy vs a decrease of 2.3 beats per minute with placebo 6 Adverse reactions with Wegovy treatment in pediatric patients aged 12 years and older were similar to those reported in adults
The risk of hypoglycemia with GLP-1 RAs is low when used as monotherapy
Both medications can cause side effects such as diarrhea, constipation, dizziness, and headache
S, especialmente en relacin con nuseas y vmitos
Respiratory failure , including acute respiratory distress syndrome , is a dangerous complication in which the lungs are unable to function properly, resulting in life-threateningly-low blood oxygen concentrations (UMMC 2012)
A nurse injects the glutathione solution directly into your vein, where it enters the bloodstream at 100 percent bioavailability